The global Hyperthyroidism Medications market was valued at US$ 466.1 million in 2023 and is projected to reach US$ 699.6 million by 2030, at a CAGR of 6.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The global key manufacturers of Hyperthyroidism Medications include Merck, Herbrand PharmaChemicals, Shanghai Zhaohui Pharmaceutical, Beijing Yanjing Pharmaceutical, Jinghua Pharmaceutical Group, Guangzhou Kanghe Pharmaceutical, Zigong Honghe Pharmaceutical, Guangdong Huanan Pharmaceutical and Zibo Wankang Pharmaceutical Chemical, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Antithyroid medications are drugs that are used to treat hyperthyroidism, a condition in which the thyroid gland produces too much thyroid hormone. These medications work by blocking the production of thyroid hormone in the thyroid gland.
This report aims to provide a comprehensive presentation of the global market for Hyperthyroidism Medications, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hyperthyroidism Medications. This report contains market size and forecasts of Hyperthyroidism Medications in global, including the following market information:
- Global Hyperthyroidism Medications Market Revenue, 2019-2024, 2025-2030, ($ millions)
- Global Hyperthyroidism Medications Market Sales, 2019-2024, 2025-2030, (K Units)
- Global top five Hyperthyroidism Medications companies in 2023 (%)
We surveyed the Hyperthyroidism Medications manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hyperthyroidism Medications Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Hyperthyroidism Medications Market Segment Percentages, by Type, 2023 (%)
- Methimazole
- Propylthiouracil
- Other
Global Hyperthyroidism Medications Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Hyperthyroidism Medications Market Segment Percentages, by Application, 2023 (%)
Global Hyperthyroidism Medications Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Hyperthyroidism Medications Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Hyperthyroidism Medications revenues in global market, 2019-2024 (Estimated), ($ millions)
- Key companies Hyperthyroidism Medications revenues share in global market, 2023 (%)
- Key companies Hyperthyroidism Medications sales in global market, 2019-2024 (Estimated), (K Units)
- Key companies Hyperthyroidism Medications sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Merck
- Herbrand PharmaChemicals
- Shanghai Zhaohui Pharmaceutical
- Beijing Yanjing Pharmaceutical
- Jinghua Pharmaceutical Group
- Guangzhou Kanghe Pharmaceutical
- Zigong Honghe Pharmaceutical
- Guangdong Huanan Pharmaceutical
- Zibo Wankang Pharmaceutical Chemical
- Qilu Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hyperthyroidism Medications, market overview.
Chapter 2: Global Hyperthyroidism Medications market size in revenue and volume.
Chapter 3: Detailed analysis of Hyperthyroidism Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hyperthyroidism Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hyperthyroidism Medications capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hyperthyroidism Medications Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hyperthyroidism Medications Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hyperthyroidism Medications Overall Market Size
2.1 Global Hyperthyroidism Medications Market Size: 2023 VS 2030
2.2 Global Hyperthyroidism Medications Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Hyperthyroidism Medications Sales: 2019-2030
3 Company Landscape
3.1 Top Hyperthyroidism Medications Players in Global Market
3.2 Top Global Hyperthyroidism Medications Companies Ranked by Revenue
3.3 Global Hyperthyroidism Medications Revenue by Companies
3.4 Global Hyperthyroidism Medications Sales by Companies
3.5 Global Hyperthyroidism Medications Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Hyperthyroidism Medications Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Hyperthyroidism Medications Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hyperthyroidism Medications Players in Global Market
3.8.1 List of Global Tier 1 Hyperthyroidism Medications Companies
3.8.2 List of Global Tier 2 and Tier 3 Hyperthyroidism Medications Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Hyperthyroidism Medications Market Size Markets, 2023 & 2030
4.1.2 Methimazole
4.1.3 Propylthiouracil
4.1.4 Other
4.2 By Type - Global Hyperthyroidism Medications Revenue & Forecasts
4.2.1 By Type - Global Hyperthyroidism Medications Revenue, 2019-2024
4.2.2 By Type - Global Hyperthyroidism Medications Revenue, 2025-2030
4.2.3 By Type - Global Hyperthyroidism Medications Revenue Market Share, 2019-2030
4.3 By Type - Global Hyperthyroidism Medications Sales & Forecasts
4.3.1 By Type - Global Hyperthyroidism Medications Sales, 2019-2024
4.3.2 By Type - Global Hyperthyroidism Medications Sales, 2025-2030
4.3.3 By Type - Global Hyperthyroidism Medications Sales Market Share, 2019-2030
4.4 By Type - Global Hyperthyroidism Medications Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hyperthyroidism Medications Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application - Global Hyperthyroidism Medications Revenue & Forecasts
5.2.1 By Application - Global Hyperthyroidism Medications Revenue, 2019-2024
5.2.2 By Application - Global Hyperthyroidism Medications Revenue, 2025-2030
5.2.3 By Application - Global Hyperthyroidism Medications Revenue Market Share, 2019-2030
5.3 By Application - Global Hyperthyroidism Medications Sales & Forecasts
5.3.1 By Application - Global Hyperthyroidism Medications Sales, 2019-2024
5.3.2 By Application - Global Hyperthyroidism Medications Sales, 2025-2030
5.3.3 By Application - Global Hyperthyroidism Medications Sales Market Share, 2019-2030
5.4 By Application - Global Hyperthyroidism Medications Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Hyperthyroidism Medications Market Size, 2023 & 2030
6.2 By Region - Global Hyperthyroidism Medications Revenue & Forecasts
6.2.1 By Region - Global Hyperthyroidism Medications Revenue, 2019-2024
6.2.2 By Region - Global Hyperthyroidism Medications Revenue, 2025-2030
6.2.3 By Region - Global Hyperthyroidism Medications Revenue Market Share, 2019-2030
6.3 By Region - Global Hyperthyroidism Medications Sales & Forecasts
6.3.1 By Region - Global Hyperthyroidism Medications Sales, 2019-2024
6.3.2 By Region - Global Hyperthyroidism Medications Sales, 2025-2030
6.3.3 By Region - Global Hyperthyroidism Medications Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Hyperthyroidism Medications Revenue, 2019-2030
6.4.2 By Country - North America Hyperthyroidism Medications Sales, 2019-2030
6.4.3 US Hyperthyroidism Medications Market Size, 2019-2030
6.4.4 Canada Hyperthyroidism Medications Market Size, 2019-2030
6.4.5 Mexico Hyperthyroidism Medications Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Hyperthyroidism Medications Revenue, 2019-2030
6.5.2 By Country - Europe Hyperthyroidism Medications Sales, 2019-2030
6.5.3 Germany Hyperthyroidism Medications Market Size, 2019-2030
6.5.4 France Hyperthyroidism Medications Market Size, 2019-2030
6.5.5 U.K. Hyperthyroidism Medications Market Size, 2019-2030
6.5.6 Italy Hyperthyroidism Medications Market Size, 2019-2030
6.5.7 Russia Hyperthyroidism Medications Market Size, 2019-2030
6.5.8 Nordic Countries Hyperthyroidism Medications Market Size, 2019-2030
6.5.9 Benelux Hyperthyroidism Medications Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Hyperthyroidism Medications Revenue, 2019-2030
6.6.2 By Region - Asia Hyperthyroidism Medications Sales, 2019-2030
6.6.3 China Hyperthyroidism Medications Market Size, 2019-2030
6.6.4 Japan Hyperthyroidism Medications Market Size, 2019-2030
6.6.5 South Korea Hyperthyroidism Medications Market Size, 2019-2030
6.6.6 Southeast Asia Hyperthyroidism Medications Market Size, 2019-2030
6.6.7 India Hyperthyroidism Medications Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Hyperthyroidism Medications Revenue, 2019-2030
6.7.2 By Country - South America Hyperthyroidism Medications Sales, 2019-2030
6.7.3 Brazil Hyperthyroidism Medications Market Size, 2019-2030
6.7.4 Argentina Hyperthyroidism Medications Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Hyperthyroidism Medications Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Hyperthyroidism Medications Sales, 2019-2030
6.8.3 Turkey Hyperthyroidism Medications Market Size, 2019-2030
6.8.4 Israel Hyperthyroidism Medications Market Size, 2019-2030
6.8.5 Saudi Arabia Hyperthyroidism Medications Market Size, 2019-2030
6.8.6 UAE Hyperthyroidism Medications Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Hyperthyroidism Medications Major Product Offerings
7.1.4 Merck Hyperthyroidism Medications Sales and Revenue in Global (2019-2024)
7.1.5 Merck Key News & Latest Developments
7.2 Herbrand PharmaChemicals
7.2.1 Herbrand PharmaChemicals Company Summary
7.2.2 Herbrand PharmaChemicals Business Overview
7.2.3 Herbrand PharmaChemicals Hyperthyroidism Medications Major Product Offerings
7.2.4 Herbrand PharmaChemicals Hyperthyroidism Medications Sales and Revenue in Global (2019-2024)
7.2.5 Herbrand PharmaChemicals Key News & Latest Developments
7.3 Shanghai Zhaohui Pharmaceutical
7.3.1 Shanghai Zhaohui Pharmaceutical Company Summary
7.3.2 Shanghai Zhaohui Pharmaceutical Business Overview
7.3.3 Shanghai Zhaohui Pharmaceutical Hyperthyroidism Medications Major Product Offerings
7.3.4 Shanghai Zhaohui Pharmaceutical Hyperthyroidism Medications Sales and Revenue in Global (2019-2024)
7.3.5 Shanghai Zhaohui Pharmaceutical Key News & Latest Developments
7.4 Beijing Yanjing Pharmaceutical
7.4.1 Beijing Yanjing Pharmaceutical Company Summary
7.4.2 Beijing Yanjing Pharmaceutical Business Overview
7.4.3 Beijing Yanjing Pharmaceutical Hyperthyroidism Medications Major Product Offerings
7.4.4 Beijing Yanjing Pharmaceutical Hyperthyroidism Medications Sales and Revenue in Global (2019-2024)
7.4.5 Beijing Yanjing Pharmaceutical Key News & Latest Developments
7.5 Jinghua Pharmaceutical Group
7.5.1 Jinghua Pharmaceutical Group Company Summary
7.5.2 Jinghua Pharmaceutical Group Business Overview
7.5.3 Jinghua Pharmaceutical Group Hyperthyroidism Medications Major Product Offerings
7.5.4 Jinghua Pharmaceutical Group Hyperthyroidism Medications Sales and Revenue in Global (2019-2024)
7.5.5 Jinghua Pharmaceutical Group Key News & Latest Developments
7.6 Guangzhou Kanghe Pharmaceutical
7.6.1 Guangzhou Kanghe Pharmaceutical Company Summary
7.6.2 Guangzhou Kanghe Pharmaceutical Business Overview
7.6.3 Guangzhou Kanghe Pharmaceutical Hyperthyroidism Medications Major Product Offerings
7.6.4 Guangzhou Kanghe Pharmaceutical Hyperthyroidism Medications Sales and Revenue in Global (2019-2024)
7.6.5 Guangzhou Kanghe Pharmaceutical Key News & Latest Developments
7.7 Zigong Honghe Pharmaceutical
7.7.1 Zigong Honghe Pharmaceutical Company Summary
7.7.2 Zigong Honghe Pharmaceutical Business Overview
7.7.3 Zigong Honghe Pharmaceutical Hyperthyroidism Medications Major Product Offerings
7.7.4 Zigong Honghe Pharmaceutical Hyperthyroidism Medications Sales and Revenue in Global (2019-2024)
7.7.5 Zigong Honghe Pharmaceutical Key News & Latest Developments
7.8 Guangdong Huanan Pharmaceutical
7.8.1 Guangdong Huanan Pharmaceutical Company Summary
7.8.2 Guangdong Huanan Pharmaceutical Business Overview
7.8.3 Guangdong Huanan Pharmaceutical Hyperthyroidism Medications Major Product Offerings
7.8.4 Guangdong Huanan Pharmaceutical Hyperthyroidism Medications Sales and Revenue in Global (2019-2024)
7.8.5 Guangdong Huanan Pharmaceutical Key News & Latest Developments
7.9 Zibo Wankang Pharmaceutical Chemical
7.9.1 Zibo Wankang Pharmaceutical Chemical Company Summary
7.9.2 Zibo Wankang Pharmaceutical Chemical Business Overview
7.9.3 Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Medications Major Product Offerings
7.9.4 Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Medications Sales and Revenue in Global (2019-2024)
7.9.5 Zibo Wankang Pharmaceutical Chemical Key News & Latest Developments
7.10 Qilu Pharmaceutical
7.10.1 Qilu Pharmaceutical Company Summary
7.10.2 Qilu Pharmaceutical Business Overview
7.10.3 Qilu Pharmaceutical Hyperthyroidism Medications Major Product Offerings
7.10.4 Qilu Pharmaceutical Hyperthyroidism Medications Sales and Revenue in Global (2019-2024)
7.10.5 Qilu Pharmaceutical Key News & Latest Developments
8 Global Hyperthyroidism Medications Production Capacity, Analysis
8.1 Global Hyperthyroidism Medications Production Capacity, 2019-2030
8.2 Hyperthyroidism Medications Production Capacity of Key Manufacturers in Global Market
8.3 Global Hyperthyroidism Medications Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hyperthyroidism Medications Supply Chain Analysis
10.1 Hyperthyroidism Medications Industry Value Chain
10.2 Hyperthyroidism Medications Upstream Market
10.3 Hyperthyroidism Medications Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hyperthyroidism Medications Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Hyperthyroidism Medications in Global Market
Table 2. Top Hyperthyroidism Medications Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Hyperthyroidism Medications Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Hyperthyroidism Medications Revenue Share by Companies, 2019-2024
Table 5. Global Hyperthyroidism Medications Sales by Companies, (K Units), 2019-2024
Table 6. Global Hyperthyroidism Medications Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Hyperthyroidism Medications Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Hyperthyroidism Medications Product Type
Table 9. List of Global Tier 1 Hyperthyroidism Medications Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hyperthyroidism Medications Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Hyperthyroidism Medications Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Hyperthyroidism Medications Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Hyperthyroidism Medications Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Hyperthyroidism Medications Sales (K Units), 2019-2024
Table 15. By Type - Global Hyperthyroidism Medications Sales (K Units), 2025-2030
Table 16. By Application ? Global Hyperthyroidism Medications Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Hyperthyroidism Medications Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Hyperthyroidism Medications Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Hyperthyroidism Medications Sales (K Units), 2019-2024
Table 20. By Application - Global Hyperthyroidism Medications Sales (K Units), 2025-2030
Table 21. By Region ? Global Hyperthyroidism Medications Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Hyperthyroidism Medications Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Hyperthyroidism Medications Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Hyperthyroidism Medications Sales (K Units), 2019-2024
Table 25. By Region - Global Hyperthyroidism Medications Sales (K Units), 2025-2030
Table 26. By Country - North America Hyperthyroidism Medications Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Hyperthyroidism Medications Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Hyperthyroidism Medications Sales, (K Units), 2019-2024
Table 29. By Country - North America Hyperthyroidism Medications Sales, (K Units), 2025-2030
Table 30. By Country - Europe Hyperthyroidism Medications Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Hyperthyroidism Medications Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Hyperthyroidism Medications Sales, (K Units), 2019-2024
Table 33. By Country - Europe Hyperthyroidism Medications Sales, (K Units), 2025-2030
Table 34. By Region - Asia Hyperthyroidism Medications Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Hyperthyroidism Medications Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Hyperthyroidism Medications Sales, (K Units), 2019-2024
Table 37. By Region - Asia Hyperthyroidism Medications Sales, (K Units), 2025-2030
Table 38. By Country - South America Hyperthyroidism Medications Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Hyperthyroidism Medications Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Hyperthyroidism Medications Sales, (K Units), 2019-2024
Table 41. By Country - South America Hyperthyroidism Medications Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Hyperthyroidism Medications Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Hyperthyroidism Medications Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Hyperthyroidism Medications Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Hyperthyroidism Medications Sales, (K Units), 2025-2030
Table 46. Merck Company Summary
Table 47. Merck Hyperthyroidism Medications Product Offerings
Table 48. Merck Hyperthyroidism Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Merck Key News & Latest Developments
Table 50. Herbrand PharmaChemicals Company Summary
Table 51. Herbrand PharmaChemicals Hyperthyroidism Medications Product Offerings
Table 52. Herbrand PharmaChemicals Hyperthyroidism Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Herbrand PharmaChemicals Key News & Latest Developments
Table 54. Shanghai Zhaohui Pharmaceutical Company Summary
Table 55. Shanghai Zhaohui Pharmaceutical Hyperthyroidism Medications Product Offerings
Table 56. Shanghai Zhaohui Pharmaceutical Hyperthyroidism Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. Shanghai Zhaohui Pharmaceutical Key News & Latest Developments
Table 58. Beijing Yanjing Pharmaceutical Company Summary
Table 59. Beijing Yanjing Pharmaceutical Hyperthyroidism Medications Product Offerings
Table 60. Beijing Yanjing Pharmaceutical Hyperthyroidism Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Beijing Yanjing Pharmaceutical Key News & Latest Developments
Table 62. Jinghua Pharmaceutical Group Company Summary
Table 63. Jinghua Pharmaceutical Group Hyperthyroidism Medications Product Offerings
Table 64. Jinghua Pharmaceutical Group Hyperthyroidism Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Jinghua Pharmaceutical Group Key News & Latest Developments
Table 66. Guangzhou Kanghe Pharmaceutical Company Summary
Table 67. Guangzhou Kanghe Pharmaceutical Hyperthyroidism Medications Product Offerings
Table 68. Guangzhou Kanghe Pharmaceutical Hyperthyroidism Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Guangzhou Kanghe Pharmaceutical Key News & Latest Developments
Table 70. Zigong Honghe Pharmaceutical Company Summary
Table 71. Zigong Honghe Pharmaceutical Hyperthyroidism Medications Product Offerings
Table 72. Zigong Honghe Pharmaceutical Hyperthyroidism Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Zigong Honghe Pharmaceutical Key News & Latest Developments
Table 74. Guangdong Huanan Pharmaceutical Company Summary
Table 75. Guangdong Huanan Pharmaceutical Hyperthyroidism Medications Product Offerings
Table 76. Guangdong Huanan Pharmaceutical Hyperthyroidism Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Guangdong Huanan Pharmaceutical Key News & Latest Developments
Table 78. Zibo Wankang Pharmaceutical Chemical Company Summary
Table 79. Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Medications Product Offerings
Table 80. Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Zibo Wankang Pharmaceutical Chemical Key News & Latest Developments
Table 82. Qilu Pharmaceutical Company Summary
Table 83. Qilu Pharmaceutical Hyperthyroidism Medications Product Offerings
Table 84. Qilu Pharmaceutical Hyperthyroidism Medications Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Qilu Pharmaceutical Key News & Latest Developments
Table 86. Hyperthyroidism Medications Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 87. Global Hyperthyroidism Medications Capacity Market Share of Key Manufacturers, 2022-2024
Table 88. Global Hyperthyroidism Medications Production by Region, 2019-2024 (K Units)
Table 89. Global Hyperthyroidism Medications Production by Region, 2025-2030 (K Units)
Table 90. Hyperthyroidism Medications Market Opportunities & Trends in Global Market
Table 91. Hyperthyroidism Medications Market Drivers in Global Market
Table 92. Hyperthyroidism Medications Market Restraints in Global Market
Table 93. Hyperthyroidism Medications Raw Materials
Table 94. Hyperthyroidism Medications Raw Materials Suppliers in Global Market
Table 95. Typical Hyperthyroidism Medications Downstream
Table 96. Hyperthyroidism Medications Downstream Clients in Global Market
Table 97. Hyperthyroidism Medications Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Hyperthyroidism Medications Segment by Type in 2023
Figure 2. Hyperthyroidism Medications Segment by Application in 2023
Figure 3. Global Hyperthyroidism Medications Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Hyperthyroidism Medications Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Hyperthyroidism Medications Revenue, 2019-2030 (US$, Mn)
Figure 7. Hyperthyroidism Medications Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Hyperthyroidism Medications Revenue in 2023
Figure 9. By Type - Global Hyperthyroidism Medications Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Hyperthyroidism Medications Revenue Market Share, 2019-2030
Figure 11. By Type - Global Hyperthyroidism Medications Sales Market Share, 2019-2030
Figure 12. By Type - Global Hyperthyroidism Medications Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Hyperthyroidism Medications Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Hyperthyroidism Medications Revenue Market Share, 2019-2030
Figure 15. By Application - Global Hyperthyroidism Medications Sales Market Share, 2019-2030
Figure 16. By Application - Global Hyperthyroidism Medications Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Hyperthyroidism Medications Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Hyperthyroidism Medications Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Hyperthyroidism Medications Revenue Market Share, 2019-2030
Figure 20. By Region - Global Hyperthyroidism Medications Sales Market Share, 2019-2030
Figure 21. By Country - North America Hyperthyroidism Medications Revenue Market Share, 2019-2030
Figure 22. By Country - North America Hyperthyroidism Medications Sales Market Share, 2019-2030
Figure 23. US Hyperthyroidism Medications Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Hyperthyroidism Medications Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Hyperthyroidism Medications Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Hyperthyroidism Medications Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Hyperthyroidism Medications Sales Market Share, 2019-2030
Figure 28. Germany Hyperthyroidism Medications Revenue, (US$, Mn), 2019-2030
Figure 29. France Hyperthyroidism Medications Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Hyperthyroidism Medications Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Hyperthyroidism Medications Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Hyperthyroidism Medications Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Hyperthyroidism Medications Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Hyperthyroidism Medications Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Hyperthyroidism Medications Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Hyperthyroidism Medications Sales Market Share, 2019-2030
Figure 37. China Hyperthyroidism Medications Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Hyperthyroidism Medications Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Hyperthyroidism Medications Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Hyperthyroidism Medications Revenue, (US$, Mn), 2019-2030
Figure 41. India Hyperthyroidism Medications Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Hyperthyroidism Medications Revenue Market Share, 2019-2030
Figure 43. By Country - South America Hyperthyroidism Medications Sales Market Share, 2019-2030
Figure 44. Brazil Hyperthyroidism Medications Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Hyperthyroidism Medications Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Hyperthyroidism Medications Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Hyperthyroidism Medications Sales Market Share, 2019-2030
Figure 48. Turkey Hyperthyroidism Medications Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Hyperthyroidism Medications Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Hyperthyroidism Medications Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Hyperthyroidism Medications Revenue, (US$, Mn), 2019-2030
Figure 52. Global Hyperthyroidism Medications Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Hyperthyroidism Medications by Region, 2023 VS 2030
Figure 54. Hyperthyroidism Medications Industry Value Chain
Figure 55. Marketing Channels
